Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Paul

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|April 26, 2022
Joint British Societies' guideline on management of cardiac arrest in the cardiac catheter laboratoryJoel Dunning, Andrew Archbold, Joseph Paul de Bono, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
Biomed Research International|June 9, 2025
Bacteriological Profile of Diabetic Wounds at Laquintinie Hospital Douala and the Antimicrobial Potential of Spiced Fish (<i>Fontitrygon margarita</i>) Liver Oil Against Multiresistant IsolatesEstelle Djeukoua Djeuya, Joseph Paul Marius Koualiagnigni, Fabrice Fabien Dongho Dongmo, et al.
JCO Precision Oncology|September 16, 2021
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)Haider Mahdi, Navid Hafez, Deborah Doroshow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2Joseph Paul Eder, Geoffrey I Shapiro, Leonard J Appleman, et al.
Breast Cancer Research and Treatment|March 14, 2022
Differences in somatic TP53 mutation type in breast tumors by race and receptor statusNijole C Pollock, Johnny R Ramroop, Heather Hampel, et al.
BMJ Open|October 21, 2018
Impact of using eHealth tools to extend health services to rural areas of Nigeria: protocol for a mixed-method, non-randomised cluster trialBassey Ebenso, Matthew John Allsop, Babasola Okusanya, et al.
Nature|November 28, 2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerThomas Powles, Joseph Paul Eder, Gregg D Fine, et al.
Head & Neck|May 12, 2020
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapyJacob Matthew Eckstein, Nicole Nolan, Erin Healy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032Neal Ready, Anna F Farago, Filippo de Braud, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|April 26, 2022
Joint British Societies' guideline on management of cardiac arrest in the cardiac catheter laboratoryJoel Dunning, Andrew Archbold, Joseph Paul de Bono, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
Biomed Research International|June 9, 2025
Bacteriological Profile of Diabetic Wounds at Laquintinie Hospital Douala and the Antimicrobial Potential of Spiced Fish (<i>Fontitrygon margarita</i>) Liver Oil Against Multiresistant IsolatesEstelle Djeukoua Djeuya, Joseph Paul Marius Koualiagnigni, Fabrice Fabien Dongho Dongmo, et al.
JCO Precision Oncology|September 16, 2021
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)Haider Mahdi, Navid Hafez, Deborah Doroshow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2Joseph Paul Eder, Geoffrey I Shapiro, Leonard J Appleman, et al.
Breast Cancer Research and Treatment|March 14, 2022
Differences in somatic TP53 mutation type in breast tumors by race and receptor statusNijole C Pollock, Johnny R Ramroop, Heather Hampel, et al.
BMJ Open|October 21, 2018
Impact of using eHealth tools to extend health services to rural areas of Nigeria: protocol for a mixed-method, non-randomised cluster trialBassey Ebenso, Matthew John Allsop, Babasola Okusanya, et al.
Nature|November 28, 2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancerThomas Powles, Joseph Paul Eder, Gregg D Fine, et al.
Head & Neck|May 12, 2020
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapyJacob Matthew Eckstein, Nicole Nolan, Erin Healy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2018
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032Neal Ready, Anna F Farago, Filippo de Braud, et al.
Pageof 18